XORTX Announces Closing of US$1.1 Million Registered Direct Offering
We received from XORTX Therapeutics Inc. and we are glad to publish the followinf press release: £CALGARY, Alberta, Oct. 29, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused on developing innovative therapies to…